List of insiders holdings for Lyell Immunopharma, Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | GLAXOSMITHKLINE PLC 10% Owner | 2022-02-10 16:51:33 | 30,253,189 0 | 30,253,189 | Form 13G |
| 2 | Bishop Hans Edgar Director | 2024-06-17 16:17:47 | 4,815,614 0 | 4,815,614 | Form 4 |
| 3 | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. 10% Owner | 2026-05-15 16:05:03 | 3,247,162 0 | 3,247,162 | Form 13G |
| 4 | ARCH Venture Fund XIII L.P. ARCH Venture Partners XIII L.P. ARCH Venture Partners XIII LLC CRANDELL KEITH NELSEN ROBERT Burow Kristina GILLIS STEVEN BERNS PAUL L BYBEE CLINTON 10% Owner | 2026-03-09 16:34:54 | 0 3,247,162 | 3,247,162 | Form 4 |
| 5 | Innovative Cellular Therapeutics Holdings Ltd 10% Owner | 2026-06-18 21:59:08 | 3,000,000 0 | 3,000,000 | Form 4 |
| 6 | Homans Elizabeth Chief Executive Officer | 2022-03-18 16:07:26 | 1,479,500 0 | 1,479,500 | Form 4 |
| 7 | Albertson Tina M. Chief Medical Officer | 2023-02-28 18:19:25 | 704,049 0 | 704,049 | Form 4 |
| 8 | Lang Matthew Chief Business Officer | 2025-02-26 19:36:04 | 668,750 0 | 668,750 | Form 4 |
| 9 | Turner Heather D Chief General Counsel | 2022-03-18 16:11:11 | 300,000 0 | 300,000 | Form 4 |
| 10 | Thompson Rahsaan Chief Legal Officer | 2023-02-28 18:15:29 | 245,000 0 | 245,000 | Form 4 |
| 11 | Klausner Richard Director | 2026-06-12 16:21:00 | 157,641 42,166 | 199,807 | Form 4 |
| 12 | Shah Smital Chief Fin. and Bus. Officer | 2026-03-16 19:26:24 | 140,000 0 | 140,000 | Form 4 |
| 13 | Seely Lynn President and CEO | 2026-06-15 18:37:17 | 73,878 0 | 73,878 | Form 4 |
| 14 | Meltz Mark A General Counsel | 2026-02-11 21:01:51 | 50,000 0 | 50,000 | Form 4 |
| 15 | FRIEDMAN CATHY Director | 2026-06-12 16:19:19 | 9,250 16,818 | 26,068 | Form 4 |
| 16 | Newton Charles W. Chief Financial Officer | 2025-08-22 16:03:25 | 15,306 10,000 | 25,306 | Form 4 |
| 17 | Shook David Chief Medical Officer | 2026-06-11 16:07:50 | 20,923 0 | 20,923 | Form 4 |
| 18 | Ramachandra Sumant Director | 2026-06-12 16:23:41 | 9,250 10,000 | 19,250 | Form 4 |
| 19 | Hill Stephen J. Chief Operating Officer | 2026-06-15 18:34:03 | 17,894 0 | 17,894 | Form 4 |
| 20 | Lee Gary K. Chief Scientific Officer | 2026-06-15 18:35:24 | 17,808 0 | 17,808 | Form 4 |
| 21 | Bulis Veronica Sanchez VP, Corporate Controller | 2026-06-15 18:32:20 | 15,420 0 | 15,420 | Form 4 |
| 22 | BRAWLEY OTIS W Director | 2026-06-12 16:17:30 | 11,032 0 | 11,032 | Form 4 |
| 23 | Bachleda Mark Director | 2026-06-12 16:16:06 | 9,250 0 | 9,250 | Form 4 |
| 24 | NABEL ELIZABETH G Director | 2026-06-12 16:22:12 | 9,250 0 | 9,250 | Form 4 |
| 25 | RIEFLIN WILLIAM JL Director | 2026-06-12 16:25:08 | 9,250 0 | 9,250 | Form 4 |